Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study
Neurology 2024 Oct 22;103(8)e209886, M Hay, F Rollot, R Casey, A Kerbrat, G Edan, G Mathey, P Labauge, J De Sèze, S Vukusic, DA Laplaud, C Papeix, T Moreau, E Thouvenot, G Defer, C Lebrun-Frénay, J Ciron, E Berger, B Stankoff, P Clavelou, E Maillart, O Heinzlef, H Zéphir, A Ruet, O Casez, S Moulin, A Al-Khedr, B Bourre, J Pelletier, L Magy, JP Neau, JP Camdessanché, I Doghri, A Wahab, M Tchikviladzé, C Labeyrie, K Hankiewicz, E Le Page, L MichelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.